| CMA Microdialysis Systems
|
|---|
 | Most physiological way of in-vivo technique for sampling, and eliminating adverse tissue reactions
|
| No purification of sample is required prior to analysis
|
| No risk of enzymatic breakdown of recovered substances
|
| Spatial resolution, allowing local sampling from very small tissue regions e.g., brain nuclei
|
| Time resolution,achieved by sampling of minute fractions at high frequency over several days
|
| FDA lends due weightage to microdialysis results in evaluation new drug applications
|
| 
|